Image-guided radiotherapy

Table of content 

1.    Introduction and summary
2.    Executive summary table
3.    Contents
4.    Abbreviations
5.    Methodology
6.    Reimbursement analysis in Austria
6.1.    Overview of the reimbursement system
6.2.    Reimbursement for image-guided radiotherapy
6.2.1.    Procedure coding
6.2.2.    Diagnosis coding
6.2.3.    Payment mechanism and reimbursement tariffs
6.2.4.    Health technology assessments by LBI-HTA
7.    Reimbursement analysis in Belgium
7.1.    Overview of the reimbursement system
7.2.    Reimbursement for image-guided radiotherapy
7.2.1.    Procedure coding
7.2.2.    Payment mechanism and reimbursement tariffs
7.2.3.    Policy considerations by the INAMI/RIZIV
7.2.3.1.    Health technology assessments by KCE
8.    Reimbursement analysis in Denmark
8.1.    Overview of the reimbursement system
8.2.    Reimbursement for image-guided radiotherapy
8.2.1.    Procedure coding 
8.2.2.    Diagnosis coding
8.2.3.    Payment mechanism and reimbursement tariffs
8.2.4.    Policy considerations
9.    Reimbursement analysis in England
9.1.    Overview of the reimbursement system
9.2.    Reimbursement for image-guided radiotherapy
9.2.1.    Procedure coding 
9.2.2.    Payment mechanism and reimbursement tariffs
9.2.3.    Policy considerations 
9.2.3.1.    Specifics of commissioning of the procedure
9.2.3.2.    Health technology assessments by NICE
10.    Reimbursement analysis in Finland
10.1.    Overview of the reimbursement system
10.2.    Reimbursement for image-guided radiotherapy
10.2.1.    Procedure coding 
10.2.2.    Diagnosis coding
10.2.3.    Payment mechanism and reimbursement tariffs
10.2.4.    Policy considerations
11.    Reimbursement analysis in France
11.1.    Overview of the reimbursement system
11.2.    Reimbursement for image-guided radiotherapy
11.2.1.    Procedure coding 
11.2.2.    Diagnosis coding
11.2.3.    Payment mechanism and reimbursement tariffs
11.2.4.    Policy considerations by HAS
12.    Reimbursement analysis in Germany
12.1.    Overview of the reimbursement system
12.2.    Reimbursement for image-guided radiotherapy
12.2.1.    Procedure coding 
12.2.2.    Payment mechanism and reimbursement tariffs
12.2.3.    Policy considerations by G-BA
13.    Reimbursement analysis in Italy
13.1.    Overview of the reimbursement system
13.2.    Reimbursement for image-guided radiotherapy
13.2.1.    Procedure coding at national level
13.2.2.    Procedure coding at regional level (Emilia-Romagna, Lombardy, Veneto regions)
13.2.3.    Payment mechanism and reimbursement tariffs at national level
13.2.4.    Payment mechanism and reimbursement tariffs at regional level
13.2.5.    Policy considerations
14.    Reimbursement analysis in the Netherlands
14.1.    Overview of the reimbursement system
14.2.    Reimbursement for image-guided radiotherapy
14.2.1.    Procedure coding 
14.2.2.    Diagnosis coding
14.2.3.    Payment mechanism and reimbursement tariffs
14.2.4.    Policy considerations by Dutch Healthcare Institute (ZIN)
15.    Reimbursement analysis in Norway
15.1.    Overview of the reimbursement system
15.2.    Reimbursement for image-guided radiotherapy
15.2.1.    Procedure coding 
15.2.2.    Diagnosis coding
15.2.3.    Payment mechanism and reimbursement tariffs
15.2.4.    Policy considerations 
16.    Reimbursement analysis in Sweden
16.1.    Overview of the reimbursement system
16.2.    Reimbursement for image-guided radiotherapy
16.2.1.    Procedure coding 
16.2.2.    Diagnosis coding
16.2.3.    Payment mechanism and reimbursement tariffs
16.2.4.    Policy considerations 
17.    Reimbursement analysis in Switzerland
17.1.    Overview of the reimbursement system
17.2.    Reimbursement for image-guided radiotherapy
17.2.1.    Procedure coding 
17.2.2.    Payment mechanism and reimbursement tariffs
17.2.3.    Policy considerations
18.    Summary of procedure codes
19.    Summary of reimbursement codes and tariffs
20.    Disclaimer